Work

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms

Year: 2018

Type: article

Source: Haematologica

DOI: 10.3324/haematol.2018.204792

Authors: Anna B. Halpern, Megan Othus, Emily M. Huebner, Bart L. Scott, Paul C. Hendrie, Mary-Elizabeth M. Percival, Pamela S. Becker, Heather A. Smith, Vivian G. Oehler, Johnnie J. Orozco, Ryan D. Cassaday, Kelda M. Gardner, Tara L. Chen, Sarah A. Buckley, Kaysey F. Orlowski, Asma Anwar, Elihu H. Estey, Roland B. Walter

Institutions: University of Washington, Fred Hutch Cancer Center, Seattle Cancer Care Alliance

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: Conquer Cancer Foundation, American Society of Clinical Oncology, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G834931733, G9000321795, G921057374

OpenAlex ID: W2900431442

FWCI: 1.368

Cites: 11

Cited by: 29

Related to: 10